My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 238

    1.

    Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension.

    Matchar DB, McCrory DC, Orlando LA, Patel MR, Patel UD, Patwardhan MB, Powers B, Samsa GP, Gray RN.

    Ann Intern Med. 2008 Jan 1;148(1):16-29. Epub 2007 Nov 5. Review.PMID: 17984484 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease.

    Kunz R, Friedrich C, Wolbers M, Mann JF.

    Ann Intern Med. 2008 Jan 1;148(1):30-48. Epub 2007 Nov 5.PMID: 17984482 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?

    Weir MR.

    Clin Ther. 2007 Sep;29(9):1803-24. Review.PMID: 18035185 [PubMed - indexed for MEDLINE]Related articles

    4.

    The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.

    Khan NA, Hemmelgarn B, Herman RJ, Bell CM, Mahon JL, Leiter LA, Rabkin SW, Hill MD, Padwal R, Touyz RM, Larochelle P, Feldman RD, Schiffrin EL, Campbell NR, Moe G, Prasad R, Arnold MO, Campbell TS, Milot A, Stone JA, Jones C, Ogilvie RI, Hamet P, Fodor G, Carruthers G, Burns KD, Ruzicka M, DeChamplain J, Pylypchuk G, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Vallée M, Howlett J, Bacon SL, Lindsay P, Gilbert RE, Lewanczuk RZ, Tobe S; Canadian Hypertension Education Program.

    Can J Cardiol. 2009 May;25(5):287-98. Review.PMID: 19417859 [PubMed - indexed for MEDLINE]Related articles

    5.

    Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II-Receptor Blockers for Ischemic Heart Disease.

    Baker WL, Coleman CI, Kluger J, Reinhart KM, Talati R, Quercia R, Phung OJ, White CM.

    Ann Intern Med. 2009 Oct 19. [Epub ahead of print]PMID: 19843530 [PubMed - as supplied by publisher]Related articlesFree article

    6.

    Debate: angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers--a gap in evidence-based medicine.

    Ball SG, White WB.

    Am J Cardiol. 2003 May 22;91(10A):15G-21G. Review.PMID: 12781904 [PubMed - indexed for MEDLINE]Related articles

    7.

    The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

    Khan NA, Hemmelgarn B, Herman RJ, Rabkin SW, McAlister FA, Bell CM, Touyz RM, Padwal R, Leiter LA, Mahon JL, Hill MD, Larochelle P, Feldman RD, Schiffrin EL, Campbell NR, Arnold MO, Moe G, Campbell TS, Milot A, Stone JA, Jones C, Ogilvie RI, Hamet P, Fodor G, Carruthers G, Burns KD, Ruzicka M, dechamplain J, Pylypchuk G, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Vallée M, Howlett J, Katzmarzyk P, Tobe S, Lewanczuk RZ; Canadian Hypertension Education Program.

    Can J Cardiol. 2008 Jun;24(6):465-75. Review.PMID: 18548143 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

    Khan NA, Hemmelgarn B, Padwal R, Larochelle P, Mahon JL, Lewanczuk RZ, McAlister FA, Rabkin SW, Hill MD, Feldman RD, Schiffrin EL, Campbell NR, Logan AG, Arnold M, Moe G, Campbell TS, Milot A, Stone JA, Jones C, Leiter LA, Ogilvie RI, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, Burns KD, Ruzicka M, deChamplain J, Pylypchuk G, Gledhill N, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Touyz RM, Tobe SW; Canadian Hypertension Education Program.

    Can J Cardiol. 2007 May 15;23(7):539-50.PMID: 17534460 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension.

    Heran BS, Wong MM, Heran IK, Wright JM.

    Cochrane Database Syst Rev. 2008 Oct 8;(4):CD003822. Review.PMID: 18843650 [PubMed - indexed for MEDLINE]Related articles

    10.

    Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.

    Kjeldsen SE, Julius S.

    Am Heart J. 2004 Nov;148(5):747-54. Review.PMID: 15523303 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis.

    Casas JP, Chua W, Loukogeorgakis S, Vallance P, Smeeth L, Hingorani AD, MacAllister RJ.

    Lancet. 2005 Dec 10;366(9502):2026-33. Review.PMID: 16338452 [PubMed - indexed for MEDLINE]Related articles

    12.

    Blood pressure lowering efficacy of renin inhibitors for primary hypertension.

    Musini VM, Fortin PM, Bassett K, Wright JM.

    Cochrane Database Syst Rev. 2008 Oct 8;(4):CD007066. Review.PMID: 18843743 [PubMed - indexed for MEDLINE]Related articles

    13.

    Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations.

    Epstein BJ, Gums JG.

    Ann Pharmacother. 2005 Mar;39(3):470-80. Epub 2005 Feb 8. Review.PMID: 15701766 [PubMed - indexed for MEDLINE]Related articles

    14.

    What have we learned from the current trials?

    Abbott KC, Bakris GL.

    Med Clin North Am. 2004 Jan;88(1):189-207. Review.PMID: 14871059 [PubMed - indexed for MEDLINE]Related articles

    15.

    The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.

    Thomas GN, Chan P, Tomlinson B.

    Drugs Aging. 2006;23(2):131-55. Review.PMID: 16536636 [PubMed - indexed for MEDLINE]Related articles

    16.

    Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care.

    Vijan S, Hayward RA.

    Ann Intern Med. 2003 Apr 1;138(7):593-602. Review.PMID: 12667032 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Pharmacologic management of diabetic nephropathy.

    Vivian EM, Rubinstein GB.

    Clin Ther. 2002 Nov;24(11):1741-56; discussion 1719. Review.PMID: 12501871 [PubMed - indexed for MEDLINE]Related articles

    18.

    Cardiovascular outcomes in high-risk patients without heart failure treated with ARBs: a systematic review and meta-analysis.

    Al Khalaf MM, Thalib L, Doi SA.

    Am J Cardiovasc Drugs. 2009;9(1):29-43. doi: 10.2165/00129784-200909010-00004. Review.PMID: 19178130 [PubMed - indexed for MEDLINE]Related articles

    19.

    Comparison of type 1 angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension.

    Weber MA.

    J Hypertens Suppl. 1997 Dec;15(6):S31-6. Review.PMID: 9493125 [PubMed - indexed for MEDLINE]Related articles

    20.

    Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.

    Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, Weiss NS.

    JAMA. 2003 May 21;289(19):2534-44.PMID: 12759325 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity